New York State Common Retirement Fund’s Ascendis Pharma ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$31.5M Sell
182,558
-21,924
-11% -$3.78M 0.04% 296
2025
Q1
$31.9M Hold
204,482
0.05% 286
2024
Q4
$28.2M Buy
204,482
+25,164
+14% +$3.46M 0.04% 337
2024
Q3
$26.8M Sell
179,318
-20,083
-10% -$3M 0.04% 369
2024
Q2
$27.2M Buy
199,401
+3,322
+2% +$453K 0.04% 389
2024
Q1
$29.6M Sell
196,079
-8,469
-4% -$1.28M 0.04% 378
2023
Q4
$25.8M Sell
204,548
-152
-0.1% -$19.1K 0.04% 420
2023
Q3
$19.2M Sell
204,700
-3
-0% -$281 0.03% 518
2023
Q2
$18.3M Sell
204,703
-43,818
-18% -$3.91M 0.02% 606
2023
Q1
$26.6M Sell
248,521
-6,985
-3% -$749K 0.04% 454
2022
Q4
$31.2M Sell
255,506
-22,611
-8% -$2.76M 0.04% 377
2022
Q3
$28.7M Buy
278,117
+4,919
+2% +$508K 0.04% 388
2022
Q2
$25.4M Sell
273,198
-23,625
-8% -$2.2M 0.03% 450
2022
Q1
$34.8M Buy
296,823
+10,291
+4% +$1.21M 0.04% 414
2021
Q4
$38.5M Sell
286,532
-46,597
-14% -$6.27M 0.04% 399
2021
Q3
$53.1M Buy
333,129
+48,461
+17% +$7.72M 0.06% 305
2021
Q2
$37.4M Buy
284,668
+8,291
+3% +$1.09M 0.04% 415
2021
Q1
$35.6M Buy
276,377
+5,535
+2% +$713K 0.04% 419
2020
Q4
$45.2M Sell
270,842
-16,824
-6% -$2.81M 0.05% 348
2020
Q3
$44.4M Buy
287,666
+33,511
+13% +$5.17M 0.05% 317
2020
Q2
$37.6M Sell
254,155
-18,829
-7% -$2.78M 0.05% 350
2020
Q1
$30.7M Buy
272,984
+15,901
+6% +$1.79M 0.05% 358
2019
Q4
$35.8M Sell
257,083
-7,200
-3% -$1M 0.04% 404
2019
Q3
$25.5M Sell
264,283
-2,365
-0.9% -$228K 0.03% 535
2019
Q2
$30.7M Buy
266,648
+33,600
+14% +$3.87M 0.04% 462
2019
Q1
$27.4M Sell
233,048
-1
-0% -$118 0.04% 502
2018
Q4
$14.6M Buy
233,049
+71,656
+44% +$4.49M 0.02% 722
2018
Q3
$11.4M Buy
161,393
+40,702
+34% +$2.88M 0.01% 939
2018
Q2
$8.03M Buy
120,691
+17,852
+17% +$1.19M 0.01% 1096
2018
Q1
$6.73M Buy
+102,839
New +$6.73M 0.01% 1119